Yanmei Zhang Selected Research

N-n-butyl haloperidol iodide

1/2019	N-n-Butyl Haloperidol Iodide Ameliorates Oxidative Stress in Mitochondria Induced by Hypoxia/Reoxygenation through the Mitochondrial c-Jun N-Terminal Kinase/Sab/Src/Reactive Oxygen Species Pathway in H9c2 Cells.
1/2018	N-n-Butyl Haloperidol Iodide, a Derivative of the Anti-psychotic Haloperidol, Antagonizes Hypoxia/Reoxygenation Injury by Inhibiting an Egr-1/ROS Positive Feedback Loop in H9c2 Cells.
6/2016	N-n-butyl haloperidol iodide ameliorates hypoxia/reoxygenation injury through modulating the LKB1/AMPK/ROS pathway in cardiac microvascular endothelial cells.
1/2016	N-n-butyl Haloperidol Iodide Protects against Hypoxia/Reoxygenation Injury in Cardiac Microvascular Endothelial Cells by Regulating the ROS/MAPK/Egr-1 Pathway.
9/2015	N-n-butyl haloperidol iodide protects cardiomyocytes against hypoxia/reoxygenation injury by inhibiting autophagy.
7/2015	Effect of N-n-butyl haloperidol iodide on ROS/JNK/Egr-1 signaling in H9c2 cells after hypoxia/reoxygenation.
1/2013	N-n-butyl haloperidol iodide ameliorates cardiomyocytes hypoxia/reoxygenation injury by extracellular calcium-dependent and -independent mechanisms.
4/2012	N-n-Butyl haloperidol iodide inhibits the augmented Na+/Ca2+ exchanger currents and L-type Ca2+ current induced by hypoxia/reoxygenation or H2O2 in cardiomyocytes.
1/2010	N-n-butyl haloperidol iodide protects cardiac microvascular endothelial cells from hypoxia/reoxygenation injury by down-regulating Egr-1 expression.
1/2007	The protective effects of N-n-butyl haloperidol iodide on myocardial ischemia-reperfusion injury in rats by inhibiting Egr-1 overexpression.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanmei Zhang Research Topics

Disease

40	Neoplasms (Cancer) 04/2022 - 08/2007
14	Hypoxia (Hypoxemia) 01/2022 - 01/2008
11	Myocardial Ischemia (Ischemic Heart Diseases) 06/2022 - 01/2007
11	Inflammation (Inflammations) 04/2022 - 01/2007
10	Reperfusion Injury 06/2022 - 01/2007
6	Breast Neoplasms (Breast Cancer) 06/2021 - 02/2015
6	Carcinogenesis 01/2021 - 07/2012
5	Malaria 05/2021 - 11/2015
5	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 07/2012
4	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 01/2017
4	Infections 01/2021 - 07/2008
3	Myocardial Infarction 06/2022 - 02/2018
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2017
3	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 06/2019
3	Adenocarcinoma of Lung 01/2022 - 08/2007
3	Neoplasm Metastasis (Metastasis) 01/2020 - 01/2020
2	Non-alcoholic Fatty Liver Disease 01/2022 - 04/2021
2	Hepatocellular Carcinoma (Hepatoma) 01/2021 - 02/2016
2	Diabetes Mellitus 01/2021 - 01/2015
2	Carcinoma (Carcinomatosis) 01/2021 - 01/2011
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2020 - 01/2017
2	Esophageal Squamous Cell Carcinoma 10/2020 - 08/2016
2	Pain (Aches) 01/2017 - 01/2016
2	Macular Degeneration (Age-Related Maculopathy) 03/2016 - 08/2015
2	Ischemia 09/2015 - 01/2008
2	Dehydration (Water Stress) 05/2011 - 01/2011
1	Lymphoma (Lymphomas) 01/2022

Drug/Important Bio-Agent (IBA)

20	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2008
10	N-n-butyl haloperidol iodideIBA 01/2019 - 01/2007
8	RNA (Ribonucleic Acid)IBA 01/2022 - 07/2012
7	Pharmaceutical PreparationsIBA 01/2021 - 01/2016
7	pevonedistatIBA 01/2020 - 10/2015
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2017
6	EnzymesIBA 04/2021 - 10/2015
6	Small Interfering RNA (siRNA)IBA 01/2020 - 02/2015
5	AntigensIBA 04/2022 - 08/2007
5	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2022 - 01/2007
5	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021 - 10/2015
5	Transcription Factors (Transcription Factor)IBA 05/2020 - 07/2015
5	RNA Polymerase IIIIBA 01/2019 - 08/2013
4	Estrogen ReceptorsIBA 05/2020 - 02/2015
3	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2011
3	Biological ProductsIBA 01/2022 - 01/2013
3	Sirtuin 1IBA 01/2022 - 01/2017
3	CateninsIBA 01/2022 - 01/2017
3	UbiquitinIBA 01/2021 - 01/2020
3	artemisinin (artemisinine)IBA 07/2020 - 11/2015
3	AndrogensIBA 01/2020 - 07/2012
3	Ligases (Synthetase)IBA 01/2020 - 03/2019
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 01/2009
3	Cullin Proteins (Cullins)IBA 01/2020 - 10/2015
3	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 03/2019 - 10/2015
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 07/2015
3	Haloperidol (Haldol)FDA LinkGeneric 01/2018 - 04/2012
3	5S Ribosomal RNAIBA 08/2017 - 11/2013
3	Retinaldehyde (Retinal)IBA 03/2016 - 01/2015
3	Peroxidase (Myeloperoxidase)IBA 01/2009 - 01/2007
2	Long Noncoding RNAIBA 01/2022 - 01/2021
2	Verapamil (Calan)FDA LinkGeneric 01/2022 - 01/2009
2	CytokinesIBA 01/2021 - 01/2017
2	Hormones (Hormone)IBA 01/2021 - 06/2016
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2016
2	Chloroquine (Aralen)FDA LinkGeneric 07/2020 - 01/2020
2	Transcription Factor TFIIB (TFIIB)IBA 05/2020 - 02/2016
2	Ethanol (Ethyl Alcohol)IBA 06/2019 - 02/2016
2	Transcription Factor TFIIIBIBA 01/2019 - 11/2013
2	Fluorouracil (Carac)FDA LinkGeneric 01/2018 - 01/2017
2	Messenger RNA (mRNA)IBA 06/2017 - 06/2011
2	Immunoglobulin E (IgE)IBA 03/2017 - 12/2009
2	Immunoglobulin G (IgG)IBA 03/2017 - 01/2017
2	Dinoprostone (PGE2)FDA Link 01/2017 - 01/2016
2	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 01/2017 - 01/2016
2	CalciumIBA 01/2013 - 01/2011
2	FructoseIBA 05/2011 - 01/2011
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 01/2011 - 01/2009
2	Malondialdehyde (Propanedial)IBA 08/2010 - 01/2009
2	Antisense OligodeoxyribonucleotidesIBA 08/2010 - 01/2008
2	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 08/2010 - 01/2010
2	Superoxide DismutaseIBA 08/2010 - 01/2009
2	Troponin IIBA 01/2008 - 01/2007
1	InflammasomesIBA 06/2022
1	geniposideIBA 06/2022
1	Oncogene Proteins (Oncogene Protein)IBA 04/2022
1	Circular RNAIBA 04/2022
1	VaccinesIBA 04/2022
1	Oleic Acid (Oleate)IBA 01/2022
1	ResveratrolIBA 01/2022
1	HydrogelsIBA 01/2022
1	LigandsIBA 01/2022
1	Metformin (Glucophage)FDA LinkGeneric 01/2022
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2022
1	Therapeutic UsesIBA 01/2022
1	TNF-Related Apoptosis-Inducing Ligand ReceptorsIBA 01/2022
1	BNT162 VaccineIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022

Therapy/Procedure

8	Therapeutics 01/2022 - 09/2010
3	Drug Therapy (Chemotherapy) 11/2020 - 01/2017
2	Radiotherapy 01/2022 - 06/2016
2	Immunotherapy 01/2022 - 01/2020
2	Transplantation 12/2021 - 03/2021